BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• 

  Biotech Bay

  3 Biotechs That Have Investors Grinning at Thanksgiving Dinner This Year

  Investors have had a decent year, but some have much to be grateful for this Thanksgiving.

  November 21, 2017

   · 

  3 min read

   · 

  Mark Terry
• 

  Genetown

  Tiny Corbus Aims to Have Four Drugs in Mid- to Late-Stage Development by Next Year

  In less than four years, Corbus has grown from a tiny startup to a public company with 60 employees and four assets in the clinic.

  November 21, 2017

   · 

  4 min read

   · 

  Alex Keown
• 

  Job Trends

  Fresenius Kabi to Create Hundreds of New Jobs in North Carolina With $100M Expansion

  Fresenius Kabi will invest $100M in eastern North Carolina as it expands its current production facility and prepares to build a new onsite manufacturing center.

  November 21, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  Drug Development

  Stanford, NCI Researchers Discover New CAR-T Target With Early Study Data

  Instead of targeting a molecule called CD19 on the surface of the cancer cells, the new therapy targets a molecule called CD22.

  November 21, 2017

   · 

  2 min read

   · 

  Mark Terry
• 

  Drug Development

  Meet the Under-the-Radar Biotech With a ‘Novel’ Alzheimer’s Candidate

  As the world watches big pharma companies take on the challenges of developing a viable therapy for ALZ’s disease, smaller companies are also attempting to blaze a treatment trail in the neurodegenerative market.

  November 21, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  BioMidwest

  2 Rivals That Could Take a Chunk of Medtronic’s Heart-Unit Sales

  The company is expected to face growing competition from Abbott and Boston Scientific in heart implants, an analyst said.

  November 21, 2017

   · 

  1 min read
• 

  Drug Development

  Cytokinetics Scraps Lead ALS Drug After Late-Stage Trial Failure

  Cytokinetics has suspended development of tirasemtiv after it failed to differentiate itself from placebo in a statistically significant manner.

  November 21, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  Amsterdam Named the New Home of the EMA

  Pharma and biotech stakeholders applauded the vote as Amsterdam achieved the hightest rate of acceptance of the EMA staff for relocatation, according to a survey.

  November 21, 2017

   · 

  1 min read
• 

  Job Trends

  Medtech Innovative Health Solutions to Create New Jobs in Expansion

  Less than one week after the FDA cleared Innovative Health Solutions’ NSS-2 Bridge, the company announced it will expand its payroll to include a number of new businesses.

  November 21, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  Biotech Bay

  Why Bay Area’s Intuitive Surgical Could be the Top Medtech Stock Right Now

  Over the years, Intuitive Surgical has carved out a place for itself as one of the few providers of minimally-invasive, robotically-assisted surgical equipment.

  November 21, 2017

   · 

  1 min read